Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TCR2 THERAPEUTICS INC.

(TCRR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about TCR2 THERAPEUTICS INC.
11/22TCR2 Therapeutics Inc. Announces Resignation of Mayur Somaiya, Effective December 10, 2..
CI
11/11Tcr-2 therapeutics reports third quarter 2021 financial results and provides corporate ..
AQ
11/10TCR2 Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate U..
PU
11/10TCR▓ Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate U..
AQ
11/10TCR2 Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months E..
CI
11/01TCR2 Therapeutics Announces Expansion of U.S. Manufacturing Capacity - Form 8-K
PU
11/01TCR▓ Therapeutics Announces Expansion of U.S. Manufacturing Capacity
AQ
11/01Tcr2 Therapeutics Inc. Announces Expansion of U.S. Manufacturing Capacity
CI
10/26TCR2 Therapeutics Announces Clinical Trial Collaboration Agreement with Bristol Myers S..
PU
10/26Tcr-2 therapeutics announces clinical trial collaboration agreement with bristol myers ..
AQ
10/25TCR2 THERAPEUTICS : Initiates Clinical Trial Partnership With Bristol Myers Squibb to Eval..
MT
10/21TCR2 THERAPEUTICS : Wedbush Trims Price Target for TCR2 Therapeutics to $10 From $11, Main..
MT
10/21TCR2 THERAPEUTICS : SVB Leerink Downgrades TCR2 Therapeutics to Market Perform from Outper..
MT
10/21TCR2 THERAPEUTICS : Tcr-2 therapeutics reviews pipeline and strategy at r&d day
AQ
10/20TCR2 THERAPEUTICS : Press release issued by TCR2 Therapeutics Inc. on October 20, 2021 - F..
PU
More most relevant news
All news about TCR2 THERAPEUTICS INC.
11/22TCR2 Therapeutics Inc. Announces Resignation of Mayur Somaiya, Effective December 10, 2..
CI
11/11Tcr-2 therapeutics reports third quarter 2021 financial results and provides corporate ..
AQ
11/10TCR2 THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and..
AQ
11/10TCR2 Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate U..
PU
11/10TCR▓ Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate U..
AQ
11/10TCR2 Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months E..
CI
11/01TCR2 Therapeutics Announces Expansion of U.S. Manufacturing Capacity - Form 8-K
PU
11/01TCR2 THERAPEUTICS INC. : Costs Associated with Exit or Disposal Activities, Financial Stat..
AQ
11/01TCR▓ Therapeutics Announces Expansion of U.S. Manufacturing Capacity
AQ
11/01Tcr2 Therapeutics Inc. Announces Expansion of U.S. Manufacturing Capacity
CI
More news
News in other languages on TCR2 THERAPEUTICS INC.
10/25TCR2 Therapeutics lance un partenariat d'essais cliniques avec Bristol Myers Squibb pou..
09/17Selon Wedbush, la thérapie TCR2 doit organiser des essais supplémentaires pour le trait..
09/17Les produits thérapeutiques TCR2 chutent après les résultats provisoires de l'essai de ..
09/17TCR2 Therapeutics annonce les résultats provisoires de l'essai de phase 1/2 sur le Gavo..
09/02TCR2 Therapeutics reçoit la désignation de médicament orphelin de la FDA pour Gavo-Cel ..
More news
Analyst Recommendations on TCR2 THERAPEUTICS INC.
10/21TCR2 THERAPEUTICS : Wedbush Trims Price Target for TCR2 Therapeutics to $10 From $11, Main..
MT
10/21TCR2 THERAPEUTICS : SVB Leerink Downgrades TCR2 Therapeutics to Market Perform from Outper..
MT
09/20TCR2 THERAPEUTICS : HC Wainwright Adjusts TCR2 Therapeutics' Price Target to $25 from $37,..
MT
09/20TCR2 THERAPEUTICS : Truist Securities Adjusts Price Target on TCR2 Therapeutics to $29 Fro..
MT
09/17TCR2 THERAPEUTICS : Wedbush Moves to the Sidelines and Downgrades TCR2 Therapeutics to Neu..
MT
More recommendations
Press releases
11/11Tcr-2 therapeutics reports third quarter 2021 financial results and provides corporate ..
AQ
11/10TCR2 THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and..
AQ
11/10TCR2 Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate U..
PU
11/10TCR▓ Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate U..
AQ
11/01TCR2 Therapeutics Announces Expansion of U.S. Manufacturing Capacity - Form 8-K
PU
More press releases
Upcoming event on TCR2 THERAPEUTICS INC.
04/04/22